세계의 신규 약물전달 시스템(NDDS) 시장

Novel Drug Delivery Systems (NDDS)

발행일: 2024년 08월 | 리서치사:

Global Industry Analysts, Inc. | 페이지 정보: 영문 492 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

신규 약물전달 시스템(NDDS) 세계 시장은 2030년까지 655억 달러에 이를 전망

2023년에 163억 달러로 추정되는 신규 약물전달 시스템(NDDS) 세계 시장은 분석 기간인 2023-2030년에 21.9%의 연평균 복합 성장률(CAGR)로 성장하여 2030년에는 655억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 NDDS용 나노입자는 CAGR 21.4%를 나타내고, 분석 기간 종료까지 519억 달러에 이를 것으로 예측됩니다. NDDS용 색전 입자 부문의 성장률은 분석 기간중 CAGR 24.1%로 추정됩니다.

미국 시장은 57억 달러로 추정, 중국은 CAGR 26.6%로 성장 예측

미국의 신규 약물전달 시스템(NDDS) 시장은 2023년에 57억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 74억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2023-2030년간 CAGR은 26.6%입니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 18.9%와 19.9%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 CAGR 20.3%를 나타낼 전망입니다.

세계 신규 약물전달 시스템(NDDS) 시장 - 주요 동향 및 촉진요인 정리

신규 약물전달 시스템(NDDS)은 환자에게 약물을 전달하는 혁신적인 방법으로 유효성, 안전성 및 치료 요법에 대한 환자의 순응도를 높이는 방식으로 약물을 전달하는 방법을 말합니다. NDDS는 체내 특정 부위에 직접 약물을 전달하여 약물 방출 속도를 제어하고 부작용을 최소화하면서 치료 지수를 최대화하도록 설계되었으며, 리포좀, 나노입자, 마이크로니들, 약물 용출 스텐트 등 다양한 약물 전달 플랫폼이 포함됩니다. 전달 플랫폼이 포함됩니다. 이러한 기술은 약물의 제어된 서방형 방출을 가능하게 하고, 투여 횟수를 줄여 환자 예후를 개선할 수 있습니다. 이 분야는 만성 질환 및 암 치료와 백신 전달에 특히 중요합니다.

연구자들과 제약회사들이 기존 약물 전달 방법의 한계를 극복하기 위해 노력하면서 NDDS의 개발은 계속 성장하고 있습니다. 기존 약물 치료의 중요한 과제 중 하나는 부작용을 일으키지 않고 약물의 최적 치료 수준을 달성하는 것이며, NDDS는 첨단 제형 기술과 엔지니어링 기술을 통해 이 과제를 단순화하는 것을 목표로 하고 있습니다. 예를 들어, 나노입자의 EPR(Enhanced permeability and retention) 효과는 종양 세포에 대한 표적화된 약물 전달을 가능하게 하여 건강한 조직에 미치는 영향을 최소화하고 암 치료의 부작용을 줄일 수 있습니다. 또한, NDDS에 생분해성 소재를 적용하면 보다 안전하고 효과적인 약물 전달 메커니즘을 촉진할 수 있어 지속 가능한 의료 행위에 대한 수요 증가에 부합합니다. 또한, 센서가 장착된 스마트 알약과 같은 약물 전달 시스템에 디지털 기술을 통합하면 약물 방출과 환자의 복약 순응도에 대한 실시간 데이터를 얻을 수 있으며, 이는 정확한 용량을 필요로 하는 치료에 필수적입니다.

신약 전달 시스템 시장의 성장은 재료과학과 생명공학의 기술 발전, 만성질환의 확산, 더 나은 맞춤형 헬스케어 솔루션을 원하는 정보에 입각한 소비자층 등 여러 요인에 의해 주도되고 있습니다. 특히 나노기술과 분자생물학의 발전은 보다 효율적인 약물 전달 시스템 개발에 큰 도움이 되고 있습니다. 이러한 기술 혁신은 약물을 생체 적합성 물질에 캡슐화하여 신체의 자연적 장벽을 우회하여 질병 부위에 직접, 제어된 속도로 약물을 방출할 수 있게 해줍니다. 또한, 당뇨병, 심장병과 같은 만성 질환의 발병률이 증가함에 따라 보다 효율적이고 편리한 약물 전달 방법에 대한 수요가 증가하고 있으며, 이는 NDDS 연구개발에 대한 추가 투자를 촉진하고 있습니다. 마지막으로, 환자들의 건강 관리 의사 결정에 대한 참여가 증가함에 따라 효과적이고 비침습적이며 편리한 약물 전달 시스템에 대한 수요가 증가하고 있으며, 이는 시장의 지속적인 성장과 혁신을 주도하고 있습니다.

조사 대상 기업 예(총 238건)

Alexza Pharmaceuticals
Ademtech SA
Acerus Pharmaceuticals Corporation
Adocia
Aerogen
Aktivax, Inc.
2C Tech
Acuitas Therapeutics
Applied Nanoparticles
Apogee Technology, Inc.
20Med Therapeutics
AnTolRx Inc.
Adipo Therapeutic
AcelRx Pharmaceuticals
Advanced NanoTherapies Inc.

The global market for Novel Drug Delivery Systems (NDDS) estimated at US$16.3 Billion in the year 2023, is expected to reach US$65.5 Billion by 2030, growing at a CAGR of 21.9% over the analysis period 2023-2030. Nanoparticles for NDDS, one of the segments analyzed in the report, is expected to record a 21.4% CAGR and reach US$51.9 Billion by the end of the analysis period. Growth in the Embolization Particles for NDDS segment is estimated at 24.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.7 Billion While China is Forecast to Grow at 26.6% CAGR

The Novel Drug Delivery Systems (NDDS) market in the U.S. is estimated at US$5.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$7.4 Billion by the year 2030 trailing a CAGR of 26.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.9% and 19.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 20.3% CAGR.

Global Novel Drug Delivery Systems (NDDS) Market - Key Trends and Drivers Summarized

Novel Drug Delivery Systems (NDDS) refer to innovative methods for delivering medication to patients in a manner that increases the efficacy, safety, and patient compliance with the treatment regimen. These systems are designed to target the delivery of drugs directly to a specific site in the body, control the rate of drug release, and maximize the therapeutic index while minimizing side effects. NDDS encompasses a variety of delivery platforms including liposomes, nanoparticles, microneedles, and drug-eluting stents, among others. These technologies enable controlled and sustained release of medications, potentially reducing dosage frequency and improving patient outcomes. This field is particularly significant in the treatment of chronic diseases, cancer, and for the delivery of vaccines.

The development of NDDS continues to grow as researchers and pharmaceutical companies aim to overcome the limitations of conventional drug delivery methods. One of the key challenges in traditional pharmacotherapy is achieving optimal therapeutic levels of a drug without causing adverse effects, a task that NDDS aims to simplify through advanced formulation and engineering techniques. Enhanced permeability and retention (EPR) effect of nanoparticles, for example, allows for targeted drug delivery to tumor cells, minimizing the impact on healthy tissues and reducing side effects in cancer treatments. Moreover, the application of biodegradable materials in NDDS promotes safer and more effective drug delivery mechanisms, aligning with the growing demand for sustainable medical practices. Additionally, the integration of digital technology into drug delivery systems, such as smart pills equipped with sensors, provides real-time data on drug release and patient adherence, which can be critical for treatments requiring precise dosages.

The growth in the Novel Drug Delivery Systems market is driven by several factors including technological advancements in material science and biotechnology, increasing prevalence of chronic diseases, and a more informed consumer base demanding better and more tailored healthcare solutions. Advancements in nanotechnology and molecular biology have been particularly instrumental in developing more efficient drug delivery systems. These innovations allow drugs to be encapsulated in biocompatible materials that can bypass the body's natural barriers and release drugs at a controlled rate directly at the disease site. Additionally, the rising incidence of chronic conditions such as diabetes and heart disease fuels the demand for more efficient and convenient drug delivery methods, encouraging further investment in NDDS research and development. Lastly, as patients become more engaged in their health care decisions, there is a growing demand for drug delivery systems that are not only effective but also non-invasive and convenient, steering the market towards sustained growth and innovation.

Select Competitors (Total 238 Featured) -

Alexza Pharmaceuticals
Ademtech SA
Acerus Pharmaceuticals Corporation
Adocia
Aerogen
Aktivax, Inc.
2C Tech
Acuitas Therapeutics
Applied Nanoparticles
Apogee Technology, Inc.
20Med Therapeutics
AnTolRx Inc.
Adipo Therapeutic
AcelRx Pharmaceuticals
Advanced NanoTherapies Inc.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Novel Drug Delivery Systems (NDDS) - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Novel Drug Delivery System (NDDS): A Prelude
- Versatile Benefits of NDDS Drive Companies to Embrace the Drug Delivery Approach
- Patient Compliance: A Key Reason Garnering Interest in NDD
- Regulatory Process for Novel Drug Delivery Systems
- A Look into Current Areas of Research in Drug Delivery
- Market Outlook
- Nanotechnology-Enabled Drug Delivery: Primary Challenges
- Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Nanotechnology Bolsters Demand for NDDS
- Prospects Remain Encouraging
- Microfluidics Mediated NDDS Set to Make Gains
- Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes
- Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery
- List of Marketed Liposome-Based Clinical Products Classified by Therapeutic Areas
- Liposomes-based Drug Delivery Systems to touch Diverse Areas of Modern Medicine
- Dendrimers as Ideal Drug Delivery Agents
- List of Commercially Available Dendrimeric Products by Application Area
- High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems
- Oral Thin Films Enhance NDDS Domain
- Nanotechnology-Enabled Drug Delivery Opens New Horizons to Improve Cancer Treatments
- Rising Cancer Incidence Drives Focus onto Novel Drug Delivery Mechanisms
- Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
- Number of New Cancer Cases and Deaths (in Million) by Region for 2020
- Global Breakdown of Total Number of Cancer Cases by Type: 2020
- Novel Drug Delivery System Emerges as a Potential Treatment for Pediatric Brain Tumors
- Uptrend in Gene Therapy Market Augurs Well for Market Growth
- Global Gene Therapy Market in US$ Million: 2020, 20223 and 2024
- Adeno-Associated Virus Vectors: A Leading Platform for Gene Therapy
- Application of Nanotechnology-based Drug Delivery Systems for CVD Treatment
- Global Annual Medical Cost of CVD in US$ Billion (2020-2030)
- NDD for Antimicrobial Drugs
- List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use
- Nanotechnology Opens New Avenues in Antiretroviral Therapy
- Demonstrated Activity of Select Nanotechnology-Delivered Antiretroviral Therapies
- Novel Drug Delivery System Exhibits Potential to Target HIV Reservoirs
- Global HIV Prevalence Seeks Need for Novel Drug Delivery Systems: Number of People Living with AIDs (in Thousands) by Region
- Novel Drug Delivery Systems for CNS Therapeutics
- Novel Drug and a New Delivery Method for Restoring Brain Cells in People Suffering from PD
- Nanotechnology Powers Next Wave of Change for Neglected Tropical Diseases' Treatment
- Novel Drug Delivery Systems Hold Edge over Existing Therapies for Diabetic Retinopathy
- Exciting Immunology Developments Involving Graphene-based Nanomaterials
- Nanotechnology-Based Strategies for siRNA Grows in Popularity
- Nanoemulsions Begin to Make a Mark
- Inorganic Nanocarriers Facilitate High Payload Capacity and Co-Delivery Platforms for MDR Cancer Therapy
- Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery
- Recent Advancements in Polymeric Drug Delivery Systems
- Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest
- Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery
- SLNs in Pulmonary Delivery of Drugs
- Other Nanocarriers in Pulmonary Delivery
- Increasing Importance of Gold Nanoparticles in Targeted Drug Administration
- Gold Nanoparticles Open New Avenues in Combinatorial Cancer Therapy
- Consistent Rise in Healthcare Spending Worldwide to Drive Market Opportunities
- World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 and 2023
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 2: World 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
- TABLE 3: World Recent Past, Current & Future Analysis for Nanoparticles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 4: World 7-Year Perspective for Nanoparticles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Embolization Particles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 6: World 7-Year Perspective for Embolization Particles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 7: World Novel Drug Delivery Systems (NDDS) Market Analysis of Annual Sales in US$ Million for Years 2020 through 2030

III. MARKET ANALYSIS

UNITED STATES
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 8: USA Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 9: USA 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
CANADA
- TABLE 10: Canada Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 11: Canada 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
JAPAN
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 12: Japan Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 13: Japan 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
CHINA
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 14: China Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 15: China 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
EUROPE
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 16: Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 17: Europe 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
- TABLE 18: Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 19: Europe 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
FRANCE
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 20: France Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 21: France 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
GERMANY
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 22: Germany Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 23: Germany 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
ITALY
- TABLE 24: Italy Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 25: Italy 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
UNITED KINGDOM
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 26: UK Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 27: UK 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
REST OF EUROPE
- TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 29: Rest of Europe 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
ASIA-PACIFIC
- Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 31: Asia-Pacific 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
REST OF WORLD
- TABLE 32: Rest of World Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 33: Rest of World 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030